Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

Southern Illinois Opioid Prescription Drug and Heroine Conference


Date: Jun 6, 2017 10:00 AM - 02:30 PM

Fee

$0.00

CE Hours

2.00

CE Units

0.200

Registration closes on Jun 06, 2017 10:00 AM

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists

Accreditation(s)

Disclosure Policy
The disclosure policies of the SIUE School of Pharmacy Office of Continuing Professional Education requires all persons in a position to control content to disclose any relevant financial relationships with commercial interests. If a conflict is identified, the Office of Professional Continuing Education will initiate a process for resolving the conflict.  The existence of relationships does not necessarily imply bias or lessen the value of the activity.  All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
The persons required to disclose conflicts include all course faculty, the SIUE CPE administrator, all activity planners and all reviewers.  The relevant commercial financial relationships or affiliations must have occured over the past 12 months.

 
Accreditation Council for Pharmacy Education
Southern Illinois University Edwardsville School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  
 
 
 
The participant must provide the correct NABP ePID number/DOB combination in their electronic profile. All CPE evaluations must be completed within 60 days of activity. It is the participant's responsibility to check that their credit records are correct within the 60 day period after completion of the activity.   Log in to CPE Monitor at www.mycpemonitor.net to view a list of all ACPE-accredited activities you have taken. Any discrepancies must be resolved with the CPE Provider directly and in a timely manner.
 
 
 

 

Requirements for CE Credit

 
To receive CE credit, the participant must complete the entire course (be present for the entire live presentation, read the monograph in its entirety etc.), complete the online pretest and post-test with a score greater than that specified for the course.   The participant must  also complete the online evaluation.
 
 
Continuing pharmacy education credit is reported to CPE Monitor once the post-test & evaluation are successfully completed.  

 

 

Registration closes on Jun 06, 2017 at 10:00 AM

Registration Closed  

Healthcare providers in Southern Illinois continue to struggle with safe prescribing and monitoring of opioid analgesics.  ILPMP data suggests that this trend is especially pronounced in the southern region of our State.  The most recent CDC report from MMWR illustrates the continued rise of opioid related overdose deaths despite our best efforts. 

Objectives

  • Identify monitoring strategies and compliance to ensure appropriate use of opioid prescriptions
  • Outline strategies to prevent opioid abuse by counseling patients on proper storage and disposal practice
  • Describe validated risk screening tools for aberrant drug taking behaviors as well as their utility and limitations
  • Select appropriate toxicology screening and interpret results to ensure safe use of opioids

Speaker(s)/Author(s)

Chris Herndon, Pharm.D., BCPS, CPE, FASHP picture

Chris Herndon, Pharm.D., BCPS, CPE, FASHP
Associate Professor of Pharmacy Practice, SIUE School of Pharmacy


Brief Bio : Associate Professor, Department of Pharmacy Practice, SIUE and Clinical Assistant Professor, Department of Community and Family Medicine, St. Louis University School of Medicine. Clinical interest: Pain Management.
Disclosure : Conflict of Interest Disclosures: The presenter has completed and submitted the SIUE School of Pharmacy Continuing Pharmacy Education Form for Disclosure of Potential Conflicts of Interest and none were reported.

Activity Number

0480-0000-17-009-L01-P
Date: 06/06/17
Time: 10:15 AM - 11:15 AM

CE Hours

1.00

Location

Mt. Vernon Hotel and Event Center
Registration Closed  

Registration Closed  

Opioid prescribing for chronic pain can be excessive and unsafe, so pharmacists need to take additional steps to increase the safe use of pain medications.   
Pharmacists will learn several ways in which they can easily collaborate with prescribers to alter their opioid prescribing and other aspects of pain treatment to decrease opioid exposure and increase safety of prescribing.

Objectives

  • Explain the importance of maximizing the use of non-pharmacological interventions to treat chronic pain
  • Describe the CDC Opioid Prescribing Guideline’s recommendation regarding dose limits
  • Specify reasons why naloxone co-prescribing might be indicated
  • List three other steps that can be taken to increase safety of opioid prescribing

Speaker(s)/Author(s)

Bob Twillman picture

Bob Twillman, Ph.D., FAPM
Executive Director, American Academy of Pain Management


Brief Bio : Bob Twillman, Ph.D., is the Executive Director for the Academy of Integrative Pain Management. Dr. Twillman oversees federal and state pain policy developments and advocates for those supporting an integrative approach to managing pain. He also serves as Chair of the Prescription Monitoring Program Advisory Committee for the Kansas Board of Pharmacy. Dr. Twillman received his Ph.D. in Clinical Psychology at the University of California in Los Angeles, and maintains a volunteer faculty appointment as Clinical Associate Professor of Psychiatry and Behavioral Sciences at the University Of Kansas School Of Medicine in Kansas City, KS.
Disclosure : The presenter has completed and submitted the SIUE School of Pharmacy Continuing Pharmacy Education Form for Disclosure of Potential Conflicts of Interest and none were reported.

Activity Number

0480-0000-17-008-L01-P
Date: 06/06/17
Time: 01:15 PM - 02:15 PM

CE Hours

1.00

Location

Mt. Vernon Hotel and Event Center
Registration Closed